Co-Authors
This is a "connection" page, showing publications co-authored by Daniele Focosi and Andreina Baj.
Connection Strength
1.730
-
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution. Emerg Microbes Infect. 2021 Dec; 10(1):1254-1256.
Score: 0.245
-
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy. J Med Virol. 2021 Dec; 93(12):6460-6461.
Score: 0.240
-
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19. Emerg Infect Dis. 2021 Oct; 27(10):2728-2731.
Score: 0.240
-
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies. Viruses. 2021 06 23; 13(7).
Score: 0.238
-
Is a single COVID-19 vaccine dose enough in convalescents ? Hum Vaccin Immunother. 2021 Sep 02; 17(9):2959-2961.
Score: 0.236
-
Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin. Life (Basel). 2021 Apr 01; 11(4).
Score: 0.234
-
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy. Emerg Microbes Infect. 2021 Dec; 10(1):710-712.
Score: 0.061
-
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy. Viruses. 2021 07 31; 13(8).
Score: 0.060
-
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients. J Med Virol. 2021 Sep; 93(9):5648-5649.
Score: 0.059
-
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients. Vaccine. 2021 04 28; 39(18):2489-2490.
Score: 0.059
-
Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy. Emerg Infect Dis. 2021 04; 27(4):1249-1251.
Score: 0.058